Ripplecreek Partners

Strategic management consulting firm to life science and technology companies, from Global 50 to startup firms.

[Ripplecreek Partners @RipplecreekPart]

Much needed: Glypican-1 shows promise as biomarker for pancreatic cancer: http://t.co/9FqHXb0J4x; http://t.co/mY1dLRD0UA.

[Ripplecreek Partners @RipplecreekPart]

Cynosure gets expanded FDA clearance of SculpSure(TM) for non-invasive abdominal lipolysis: http://t.co/XeWZQ1DA7r

[Ripplecreek Partners @RipplecreekPart]

The future of cancer treatment? Study testing personalized immune system response shows proof of concept (Science): http://t.co/6oWAdIV1t9

[Ripplecreek Partners @RipplecreekPart]

Brave new world: What FDA's approval of 23andMe Means for Future of Genomics: http://t.co/umKAOjWaYe

[Ripplecreek Partners @RipplecreekPart]

FDA approves anti-clotting drug Savaysa to reduce risk of stroke and blood clots in AFib patients: http://t.co/MazInvwfV2.

[Ripplecreek Partners @RipplecreekPart]

New diagnostic for football players suffering from mild, 'unreported' concussions: http://t.co/E1h0fUzGy5

[Ripplecreek Partners @RipplecreekPart]

Get Well Network acquires Marbella to target mobile apps for patient engagement & feedback: http://t.co/tCn4tVra7L #patientexperience

[Ripplecreek Partners @RipplecreekPart]

Cynosure receives expanded FDA clearance of PicoSure for Acne Scar Treatment: http://t.co/o1CL12W1Kd

[Ripplecreek Partners @RipplecreekPart]

Early positive results for Alzheimer's diagnostic blood test from Georgetown: http://t.co/3eAkU3Ls19

[Ripplecreek Partners @RipplecreekPart]

FDA clears Re-Walk Exoskeleton that will let parpalegics walk again:http://t.co/kvbmFPJJGn

[Ripplecreek Partners @RipplecreekPart]

In 1Q 2014, early stage medical device funding rose 11% to $216MM via 25 deals: http://t.co/YT1EoFKCuC

[Ripplecreek Partners @RipplecreekPart]

FDA clears first HPV test for primary cervical cancer screening. http://t.co/CByPrkuxi0

[Ripplecreek Partners @RipplecreekPart]

$25.8B in Deals Reshape Novartis, GSK, Lilly.
http://t.co/h0gcq5YA1l

[Ripplecreek Partners @RipplecreekPart]

FDA clears ResolutionMD Dx imaging app for broad application (angiography, NM, ultrasound, ophthalmology, etc.):
http://t.co/WAdpUmvhZJ

[Ripplecreek Partners @RipplecreekPart]

Molecular pathology reimbursement: excellent overview and resources:
http://t.co/Md5oH3lJ5n